GlassScriptPhysician profile
Casey J Scott
NPI 1417206491
$2,348.23
in general payments reported to CMS, 2019-2025
20 companies · $29.36 in 2025
The $29.36 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $325 · 2023: $713 · 2024: $466 · 2025: $29.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $643.82 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $423.20 | 2021-2024 | Caplyta |
| Corium, LLC | $250.43 | 2021-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $235.16 | 2021-2024 | Qelbree, Qelbree |
| Tris Pharma INC | $200.61 | 2022-2023 | Dyanavel Xr, Quillivant, Quillichew Er |
| Takeda Pharmaceuticals U.S.A., INC. | $84.73 | 2021-2024 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $73.19 | 2021-2023 | Austedo |
| Otsuka America Pharmaceutical, INC. | $67.83 | 2021 | |
| Ironshore Pharmaceuticals INC. | $54.53 | 2022-2023 | Jornay Pm |
| Adlon Therapeutics L.P. | $49.04 | 2021 | |
| Noven Therapeutics, LLC | $38.32 | 2023 | Xelstrym |
| Idorsia Pharmaceuticals US INC | $35.72 | 2023 | Quviviq |
| Neos Therapeutics, LP | $35.36 | 2021 | |
| Jazz Pharmaceuticals INC. | $34.27 | 2021 | |
| Conmed Corporation | $29.36 | 2025 | System 2450, Airseal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $27.15 | 2022-2023 | Aplenzin |
| Sunovion Pharmaceuticals INC. | $19.42 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.77 | 2024 | Spravato |
| Almatica Pharma LLC | $15.71 | 2022 | |
| Eisai INC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.